1. Report Introduction 2. Malignant Mesothelioma : Overview • Risk Factors • Causes • Symptoms • Pathophysiology • Prognosis • Diagnosis • Treatment 3. Comparative Analysis of Marketed and Emerging Products 4. Marketed Therapies 4.1. Drug 1: Company name • Product Description • Route of Synthesis • Mechanism of Action • Pharmacology • Pharmacodynamics • Pharmacokinetics • Adverse Reactions • Clinical Trials • Regulatory Milestones • Product Development Activities 4.1.1 Product Details • United States • Europe 4.1.2 Global Sales Assessment • Historical Global Sales • Forecasted Global Sales 4.1.3 Patent Details Other marketed products in the detailed report….. 5. Emerging Therapies (Phase III) 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 5.1.1 Forecasted Global Sales Other Phase III profiles in the detailed report….. Appendix Methodology Consulting Services About DelveInsight Contact Us

Table 1: List of Marketed and Emerging Products Table 2: Drug Product Details, United States Table 3: Drug Product Details, Europe Table 4: Drug, Historical Global Sales till 2018 (in million USD) Table 5: Drug, Forecasted Global Sales from 2019-2021 (in million USD) Table 6: API Manufacturers Region wise Table 7: API Manufacturers for United States Table 8: API Manufacturers for Europe Table 9: API Manufacturers for China Table 10: API Manufacturers for India Table 11: Patent Details Table 12: Emerging Therapies (Phase III) Table 13: Drug, Forecasted Global Sales from 2019-2021 (in million USD) Figure 1: Comparative Analysis of Marketed and Emerging Products Figure 2: Drug, Historical Global Sales till 2018 (in million USD) Figure 3: Drug, Forecasted Global Sales from 2019-2021 (in million USD) Figure 4: Patent Details Figure 5: API Manufacturers Region wise Figure 6: Drug, Forecasted Global Sales from 2019-2021 (in million USD)